Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Springer

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Cancer Detection and Prevention|January 1, 1983
T antigen, a tumor marker against which breast, lung and pancreas carcinoma patients mount immune responsesG F Springer, P R Desai, W A Fry, et al.
Cancer Detection and Prevention|January 1, 1985
Further studies on the detection of early lung and breast carcinoma by T antigenG F Springer, W A Fry, P R Desai, et al.
Cancer|February 1, 1985
Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human seraG F Springer, C R Taylor, D R Howard, et al.
Symposium on Fundamental Cancer Research|January 1, 1983
Phenotypic and genotypic differences between high- and low-metastatic related tumor lines and the problem of tumor progression and variant generationV Schirrmacher, R Dzarlieva, P Altevogt, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Cancer Detection and Prevention|January 1, 1983
T antigen, a tumor marker against which breast, lung and pancreas carcinoma patients mount immune responsesG F Springer, P R Desai, W A Fry, et al.
Cancer Detection and Prevention|January 1, 1985
Further studies on the detection of early lung and breast carcinoma by T antigenG F Springer, W A Fry, P R Desai, et al.
Cancer|February 1, 1985
Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human seraG F Springer, C R Taylor, D R Howard, et al.
Symposium on Fundamental Cancer Research|January 1, 1983
Phenotypic and genotypic differences between high- and low-metastatic related tumor lines and the problem of tumor progression and variant generationV Schirrmacher, R Dzarlieva, P Altevogt, et al.
Pageof 12